ensysce.com (ENSC): Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

The market capitalization trend for Ensysce Biosciences (ENSC) reflects an EV/EBITDA value of 0.00, while patent protection for TAAP and MPAR systems creates significant barriers to entry for competitors. The business is based on developing unique methods for combating opioid addiction, ensuring technological superiority within the industry. Developments regarding gastrointestinal drug safety are constrained by strict regulatory oversight and the high cost of FDA certification.

ENSC Ensysce Biosciences, Inc.: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ing interval 23.11.2025 - 10.11.2026

ensysce.com - rincian analitis lan metrik utama (ENSC)

- rega saiki lan proyeksi nilai saham:

Rega saham Ensysce Biosciences, Inc.|ENSC - Prakiraan konsensus analis

- data kapitalisasi bursa:

Nilai pasar Ensysce Biosciences, Inc.|ENSC - Nilai Dipunlarasaken Utang lan Kas

- indikator nilai buku ekuitas:

Aset Bersih saben Siji Saham Ensysce Biosciences|ENSC - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku ensysce.com|ENSC - Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Utang marang Ekuitas Ensysce Biosciences|ENSC - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Ensysce Biosciences, Inc.|ENSC - Gunggung kewajiban utang perusahaan|Utang marang nilai buku Ensysce Biosciences, Inc.|ENSC - Utang jangka dawa|Utang jangka cendhak perusahaan Ensysce Biosciences|Rasio cepet ensysce.com

- data bathi bisnis lan rasio investasi:

ENSC - Penghasilan resik|Proyeksi bathi mangsa ngarep Ensysce Biosciences|ENSC - Kapitalisasi marang bathi|Prakiraan rega marang bathi Ensysce Biosciences, Inc.|ENSC - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Ensysce Biosciences, Inc.|ENSC - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Ensysce Biosciences|ENSC - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ensysce.com|ENSC - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Ensysce Biosciences

Analisis komprehensif perusahaan:Ensysce (ENSC)

Ensysce Biosciences (ENSC) is developing an innovative patent portfolio to combat opioid addiction with the support of US government institutions. The EV/EBITDA multiple on the GURU.Markets chart compares the total enterprise value, including net debt, against operating profit before taxes. This price action allows investors to assess the real value of assets and the capital stability of Ensysce Biosciences (ENSC) amid a high debt load.

Analisis pesaing